1. | Faust PL, et al. (1985) Cloning and sequence analysis of cDNA for human cathepsin D. Proc. Natl. Acad. Sci. U.S.A. 82(15):4910-4 [PubMed:3927292] |
2. | Westley BR and May FE (1987) Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res. 15(9):3773-86 [PubMed:3588310] |
3. | Redecker B, et al. Molecular organization of the human cathepsin D gene. DNA Cell Biol. 10(6):423-31 [PubMed:2069717] |
4. | Gerhard DS, et al. (2004) The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 14(10B):2121-7 [PubMed:15489334] |
5. | May FE, et al. (1993) The human cathepsin D-encoding gene is transcribed from an estrogen-regulated and a constitutive start point. Gene 134(2):277-82 [PubMed:8262386] |
6. | Augereau P, et al. (1994) Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 8(6):693-703 [PubMed:7935485] |
7. | Kobayashi T, et al. (1992) Proteolytic processing sites producing the mature form of human cathepsin D. Int. J. Biochem. 24(9):1487-91 [PubMed:1426530] |
8. | Basrur V, et al. Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. J. Proteome Res. 2(1):69-79 [PubMed:12643545] |
9. | Zhang H, et al. (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21(6):660-6 [PubMed:12754519] |
10. | Liu T, et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 4(6):2070-80 [PubMed:16335952] |
11. | Siintola E, et al. (2006) Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129(Pt 6):1438-45 [PubMed:16670177] |
12. | Chi A, et al. (2006) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J. Proteome Res. 5(11):3135-44 [PubMed:17081065] |
13. | Lewandrowski U, et al. (2006) Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol. Cell Proteomics 5(2):226-33 [PubMed:16263699] |
14. | Chen R, et al. (2009) Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 8(2):651-61 [PubMed:19159218] |
15. | Didangelos A, et al. (2010) Proteomics characterization of extracellular space components in the human aorta. Mol. Cell Proteomics 9(9):2048-62 [PubMed:20551380] |
16. | Burkard TR, et al. (2011) Initial characterization of the human central proteome. BMC Syst Biol 5:17 [PubMed:21269460] |
17. | Halim A, et al. (2013) LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. J. Proteome Res. 12(2):573-84 [PubMed:23234360] |
18. | Vaca Jacome AS, et al. (2015) N-terminome analysis of the human mitochondrial proteome. Proteomics 15(14):2519-24. doi:10.1002/pmic.201400617 [PubMed:25944712] |
19. | Letronne F, et al. (2016) ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease. EBioMedicine 9:278-92. doi:10.1016/j.ebiom.2016.06.002 [PubMed:27333034] |
20. | Metcalf P and Fusek M (1993) Two crystal structures for cathepsin D: the lysosomal targeting signal and active site. EMBO J. 12(4):1293-302 [PubMed:8467789] |
21. | Baldwin ET, et al. (1993) Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc. Natl. Acad. Sci. U.S.A. 90(14):6796-800 [PubMed:8393577] |
22. | Papassotiropoulos A, et al. (2000) A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann. Neurol. 47(3):399-403 [PubMed:10716266] |
23. | Steinfeld R, et al. (2006) Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am. J. Hum. Genet. 78(6):988-98 [PubMed:16685649] |
24. | Kousi M, et al. (2012) Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum. Mutat. 33(1):42-63 [PubMed:21990111] |
25. | Hu S, et al. (2010) Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res (Hoboken) 62(11):1633-8 [PubMed:20617533] |
26. | Schwenk JM, et al. (2017) The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays. J. Proteome Res. 16(12):4299-4310. doi:10.1021/acs.jproteome.7b00467 [PubMed:28938075] |